Cas:30273-47-3 4-Bromo-5-chloro-2-methylaniline manufacturer & supplier

Chemical Name:4-Bromo-5-chloro-2-methylaniline

CAS.NO:30273-47-3

Synonyms:BENZENAMINE,4-BROMO-5-CHLORO-2-METHYL;2-methyl-4-bromo-5-chloroaniline;4-Bromo-5-chloro-2-methylaniline;4-bromo-5-chloro-2-methyl aniline;Benzenamine, 4-bromo-5-chloro-2-methyl-

Molecular Formula:C₇H₇BrClN

Molecular Weight:220.494

HS Code:2921430090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:292.0±35.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.621

PSA:26.02000

Exact Mass:218.945038

LogP:3.30

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like BENZENAMINE,4-BROMO-5-CHLORO-2-METHYL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenamine, 4-bromo-5-chloro-2-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,BENZENAMINE,4-BROMO-5-CHLORO-2-METHYL Use and application,Benzenamine, 4-bromo-5-chloro-2-methyl- technical grade,usp/ep/jp grade.

Related News: Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 4-Bromo-5-chloro-2-methylaniline manufacturer By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. 4-Bromo-5-chloro-2-methylaniline supplier Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 4-Bromo-5-chloro-2-methylaniline vendor Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. 4-Bromo-5-chloro-2-methylaniline factory Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.